Yubo International Biotech Ltd SEC filings YBGJ

Yubo International Biotech Ltd has 284 filings in SEC EDGAR's recent list, going back to May 29, 1996. Its latest annual report, Form ARS, was filed on Jun 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jan 16, 2026 (auditor change). The company's fiscal year ends on December 31.

Form Description Filed Period
424B3 Prospectus Nov 16, 2022 —
424B3 Prospectus Aug 15, 2022 —
424B3 Prospectus Aug 1, 2022 —
S-1/A Amended registration statement Jul 21, 2022 —
S-1/A Amended registration statement Jul 8, 2022 —
S-1/A Amended registration statement Jun 10, 2022 —
S-1/A Amended registration statement Apr 20, 2022 —
S-1/A Amended registration statement Feb 11, 2022 —
S-1/A Amended registration statement Dec 9, 2021 —
S-1/A Amended registration statement Oct 12, 2021 —
S-1/A Amended registration statement Aug 3, 2021 —
S-1/A Amended registration statement Jul 12, 2021 —
S-1 Registration statement May 6, 2021 —
S-8 Employee stock plan registration Oct 13, 2000 —
S-8 Employee stock plan registration Apr 25, 2000 —

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
YBGJ (OTC)
Fiscal year ends
December 31
Incorporated in
NY
Headquarters
Beijing, China
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
895464
Former names
MAGNA LAB INC (until Dec 4, 2020)

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.